These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39072305)

  • 1. Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative.
    Claessens Z; Lammens M; Barbier L; Huys I
    J Mark Access Health Policy; 2024 Sep; 12(3):144-157. PubMed ID: 39072305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries' past health technology assessments.
    Vreman RA; van Hoof D; Nachtnebel A; Daems J; van de Casteele M; Fogarty E; Adams R; Timmers L
    Int J Technol Assess Health Care; 2023 Jun; 39(1):e44. PubMed ID: 37317832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Ready for the future?" - Status of national and cross-country horizon scanning systems for medicines in European countries.
    Vogler S
    Ger Med Sci; 2022; 20():Doc05. PubMed ID: 35465640
    [No Abstract]   [Full Text] [Related]  

  • 4. Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks.
    Desmet T; Brijs M; Vanderdonck F; Tops S; Simoens S; Huys I
    Front Pharmacol; 2024; 15():1369508. PubMed ID: 38659588
    [No Abstract]   [Full Text] [Related]  

  • 5. Value added medicines: what value repurposed medicines might bring to society?
    Toumi M; Rémuzat C
    J Mark Access Health Policy; 2017; 5(1):1264717. PubMed ID: 28265347
    [No Abstract]   [Full Text] [Related]  

  • 6. [European Collaboration in Medical Device Assessment: One Step Towards Cross-Border Health Care].
    Mayer J; Ettinger S; Nachtnebel A
    Gesundheitswesen; 2018 Mar; 80(3):210-216. PubMed ID: 28628932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.
    Aryankhesal A; Behzadifar M; Bakhtiari A; Shahabi S; Azari S; Darvishi Teli B; Rezapour A; Ehsanzadeh SJ; Behzadifar M
    Health Res Policy Syst; 2024 Jan; 22(1):11. PubMed ID: 38225573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains.
    Zimmermann G; Michelmore S; Hiligsmann M
    Int J Technol Assess Health Care; 2023 May; 39(1):e29. PubMed ID: 37212049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Policy developments of health technology assessment in the European Union].
    Baran-Kooiker A; Czech M; Hołownia-Voloskova M
    Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European access academy.
    Julian E; Pavlovic M; Sola-Morales O; Gianfrate F; Toumi M; Bucher HC; Dierks C; Greiner W; Mol P; Bergmann JF; Salmonson T; Hebborn A; Grande M; Cardone A; Ruof J
    Health Econ Rev; 2022 Nov; 12(1):54. PubMed ID: 36333433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can a joint European health technology assessment provide an 'additional benefit' over the current standard of national assessments? : Insights generated from a multi-stakeholder survey in hematology/oncology.
    Julian E; Gianfrate F; Sola-Morales O; Mol P; Bergmann JF; Salmonson T; Hebborn A; Grande M; Ruof J
    Health Econ Rev; 2022 Jun; 12(1):30. PubMed ID: 35652987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HTA goes Europe: European collaboration on joint assessment and methodological issues becomes reality].
    Nachtnebel A; Mayer J; Erdös J; Lampe K; Kleijnen S; Schnell-Inderst P; Wild C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):291-9. PubMed ID: 26354129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access in all areas? a round up of developments in market access and health technology assessment: part 4.
    Beattie A; Treharne C; Ramagopalan SV
    J Comp Eff Res; 2024 Jun; 13(6):e240060. PubMed ID: 38647164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders.
    Facey KM; Rannanheimo P; Batchelor L; Borchardt M; de Cock J
    Int J Technol Assess Health Care; 2020 Sep; ():1-10. PubMed ID: 32878663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders.
    Wasir R; Irawati S; Makady A; Postma M; Goettsch W; Feenstra T; Buskens E
    PLoS One; 2019; 14(11):e0225626. PubMed ID: 31774854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teleoperator-Robot-Human Interaction in Manufacturing: Perspectives from Industry, Robot Manufacturers, and Researchers.
    Kim S; Hernandez I; Nussbaum MA; Lim S
    IISE Trans Occup Ergon Hum Factors; 2024; 12(1-2):28-40. PubMed ID: 38328969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient advocacy group involvement in health technology assessments: an observational study.
    Single A; Cabrera A; Fifer S; Tsai J; Paik JY; Hope P
    Res Involv Engagem; 2021 Nov; 7(1):83. PubMed ID: 34823610
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.